Erratum: Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo (British Journal of Pharmacology (2003) 140 (1057-1067) DOI: 10.1038/sj.bjp.0705525));Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo

British Journal of Pharmacology

Volumn 140, Issue 6, 2003, Pages 1057-1067

  Estellés, Rossana ^a   López Martín, Javier ^a   Milian, Lara ^a   O'Connor, José Enrique ^a   Martínez Losa, Magdalena ^a   Cerdá Nicolás, Miguel ^a   Anam, Edet M ^b   Ivorra, María Dolores ^a   Issekutz, Andrew C ^c   Cortijo, Julio ^a   Morcillo, Esteban J ^a   Blázquez, María Amparo ^a   Sanz, María Jesús ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Angiotensin II; Endothelium; Intravital microscopy; Leukocyte; Phenanthrene alkaloids

Indexed keywords

ALKALOID DERIVATIVE; ANGIOTENSIN; CALCIUM ION; CYCLIC AMP; FREE RADICAL; HYDROGEN PEROXIDE; HYPOXANTHINE; PADGEM PROTEIN; PHENANTHRENE DERIVATIVE; REACTIVE OXYGEN METABOLITE; STEPHENANTHRINE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG; UVARIOPSINE; XANTHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ADHESION; CELL INTERACTION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LEUKOCYTE; LEUKOCYTE ACTIVATION; MALE; MESENTERY BLOOD FLOW; MICROCIRCULATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0344394484     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705525     Document Type: Erratum

References (39)

1. ADAMS, D.H. & SHAW, S. (1994). Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet, 343, 831-836.
2. ÁLVAREZ, A., PIQUERAS, L., BLÁZQUEZ, M.A. & SANZ, M.J. (2001). Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. Br. J. Pharmacol., 133, 485-494.
3. ÁLVAREZ, A. & SANZ, M.J. (2001). Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J. Leukoc. Biol., 70, 199-206.
4. BERGMEYER, H.U. & BERNT, E. (1974). Lactate dehydrogenase: UV assay with pyruvate and NADH. In: Methods of Enzymatic Analysis. ed. Bergmeyer H.U., pp 574-577. New York: Academic Press.
5. BUTCHER, E.C. (1991). Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell, 67, 1033-1036.
6. CHENG, K.S., KO, F.N., TENG, C.M. & WU, Y.C. (1996). Antiplatelet and vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. J. Nat. Prod., 59, 531-534.
7. CYBULSKY, M.I. & GIMBRONE JR, M.A. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 251, 788-791.
8. DASI, F.J., ORTIZ, J.L., CORTIJO, J. & MORCILLO, E.J. (2000). Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils. Inflamm. Res., 49, 600-609.
9. DERIAN, C.K., SANTULLI, R.J., RAO, P.E., SOLOMON, H.F. & BARRETT, J.A. (1995). Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cyclic AMP modulators. J. Immunol., 154, 308-317.
10. FARBER, H.W., CENTER, D.M., ROUNDS, S. & DANILOV, S.M. (1990). Components of the angiotensin system cause the release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur. Heart J., 11 (Suppl. B), 100-107.
11. GABOURY, J.P., ANDERSON, D.C. & KUBES, P. (1994). Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. Am. J. Physiol., 266, H637-H642.
12. GRÄFE, M., AUCH-SCHWELK, W., ZAKRZEWICZ, A., REGITZ-ZAGROSEK, V., BARTSCH, P., GRAF, K., LOEBE, M., GAEHTGENS, P. & FLECK, E. (1997). Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ. Res., 81, 804-811.
13. HAHN, A.W., JONAS, U., BÜHLER, F.R. & RESINK, T.J. (1994). Activation of human peripheral monocytes by angiotensin II. FEBS Lett., 347, 178-180.
14. HERNÁNDEZ-PRESA, M., BUSTOS, C., ORTEGO, M., TUÑON, J., RENEDO, G., RUIZ-ORTEGA, M. & EGIDO, J. (1997). Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation, 95, 1532-1541.
15. HOUSE, S.D. & LIPOWSKY, H.H. (1987). Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc. Res., 34, 363-379.
16. JAFFE, E.A., NACHMAN, R.L., BECKER, C.G. & MINICK, C.R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52, 2745-2756.
17. JANTAN, I., RAFI, I.A. & JALIL, J. (2001). Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. Planta Med., 67, 466-467.
18. JOHNSTON, B., KANWAR, S. & KUBES, P. (1996). Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am. J. Physiol., 271, H614-H621.
19. KIM, J.A., BERLINER, J.A. & NADLER, J.R. (1996). Angiotensin II increases monocyte binding to endothelial cells. Biochem. Biophys. Res. Commun., 226, 862-868.
20. LAURSEN, J.B., RAJAGOPALAN, A., GALIS, Z., TARPEY, M., FREEMAN, B.A. & HARRISON, D.G. (1997). Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation, 95, 588-593.
21. LI, X.J., ZHAO, B.L., LIU, G.T. & XING, W.J. (1990). Scavenging effects on active oxygen free radicals by schisandrins with different structures and configurations. Free Radical Biol. Med., 9, 99-104.
22. LÓPEZ-MARTÍN, J., ANAM, E.M., BOIRA, H., SANZ, M.J. & BLÁZQUEZ, M.A. (2002). Chromone and phenanthrene alkaloids from Dennettia tripetala. Chem. Pharm. Bull., 50, 1613-1615.
23. MERVAALA, E.M.A., MÜLLER, D.M., PARK, J.K., SCHMIDT, F., LÖHN, M., BREU, V., DRAGUN, D., GANTEN, D., HALLER, H. & LUFT, F.C. (1999). Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension, 33, 389-395.
24. MÜGGE, A., ELWELL, J.H., PETERSON, T.E., HOFMEYER, T.G., HEISTAD, D.D. & HARRISON, D.G. (1991). Chronic treatment with polyethylene- glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res., 69, 1293-1300.
25. 2 receptor-mediated P-selectin upregulation. Circulation, 102, 2118-2123.
26. PRICE, D.T. & LOSCALZO, J. (1999). Cellular adhesion molecules and atherogenesis. Am. J. Med., 107, 85-97.
27. ROSS, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
28. SANZ, M.J., ALVAREZ, A., PIQUERAS, L., CERDA, M., ISSEKUTZ, A.C., LOBB, R.R., CORTIJO, J. & MORCILLO, E.J. (2002). Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P-and E-selectin downregulation. Br. J. Pharmacol., 135, 1872-1881.
29. SCHUDT, C., WINDER., S., FORDERKUNZ, S., HATZELMANN, A. & ULLRICH, V. (1991). Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Ca. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 682-690.
30. SEKIGUCHI, T. & NAGAMINE, T. (1994). Inhibition of free radical generation by biotin. Biochem. Pharmacol., 47, 594-596.
31. SHIMADA, K. & YAZAKI, Y. (1978). Binding sites for angiotensin II in human mononuclear leukocytes. J. Biochem., 84, 1013-1015.
32. SIMONCINI, T., MAFFEI, S., BASTA, G., BARSACCHI, G., GENAZZANI, A.R., LIAO, J.K. & DE CATERINA, R. (2000). Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res., 87, 19-25.
33. SPRINGER, T.A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
34. SZUCS, S., VAMOSI, G., POKA, R., SARVARY, A., BARDOS, H., BALAZS, M., KAPPELMAYER, J., TOTH, L., SZOLLOSI, J. & ADANY, R. (1998). Single-cell measurement of superoxide anion and hydrogen peroxide production by human neutrophils with digital imaging fluorescence microscopy. Cytometry, 33, 9-31.
35. TENG, C.M., HSUEH, C.M., CHANG, Y.L., KO, F.N., LEE, S.S. & LIU, K.C. (1997). Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. J. Pharm. Pharmacol., 49, 706-711.
36. VASANGE, M., ROLFSEN, W. & BOHLIN, L. (1997). A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. J. Pharm. Pharmacol., 49, 562-566.
37. WALTER, U.M., AYER, L.M., WOLITZKY, B.A., WAGNER, D.D., HYNES, R.O., MANNING, A.M. & ISSEKUTZ, A.C. (1997). Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in P-selectin-deficient mouse. Hybridoma, 16, 249-257.
38. YIM, T.K. & KO, K.M. (1998). Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats. Biochem. Pharmacol., 57, 77-81.
39. ZHANG, H., SCHMEISSER, A., GARLICHS, C.D., PLOTZE, K., DAMME, U., MUGGE, A. & DANIEL, W.G. (1999). Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res., 44, 215-222.